Outcome and characteristics of patients with advanced gynaecological malignancies enrolled in phase I trials

被引：0
|
作者：
Rouge, T. de La Motte [1 ]
Roca, C. Gomez [1 ]
Bahleda, R. [1 ]
Gombos, A. [1 ]
Pautier, P. [1 ]
Soria, J. C. [1 ]
Lhomme, C. [1 ]
Massard, C. [1 ]
机构：
[1] Inst Gustave Roussy, Villejuif, France
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：136 / 136
页数：1
相关论文
共 50 条
  • [1] Characteristics and outcome of pediatric patients enrolled in phase I oncology trials
    Kim, AeRang
    Fox, Elizabeth
    Warren, Katherine
    Blaney, Susan M.
    Berg, Stacey L.
    Adamson, Peter C.
    Libucha, Madeleine
    Byrley, Elena
    Balis, Frank M.
    Widemann, Brigitte C.
    ONCOLOGIST, 2008, 13 (06): : 679 - 689
  • [2] Profile and outcome of cancer patients enrolled in contemporary phase I trials
    Alouani, Emily
    Gazzah, Anas
    Mercier, Sandrine
    Bahleda, Ratislav
    Hollebecque, Antoine
    Michot, Jean-Marie
    Baldini, Capucine
    Ammari, Samy
    Champiat, Stephane
    Marabelle, Aurelien
    Postel-Vinay, Sophie
    Ribrag, Vincent
    Loriot, Yohann
    Aix, Santiago Ponce
    Mahjoubi, Linda
    EUROPEAN JOURNAL OF CANCER, 2023, 188 : 1 - 7
  • [3] Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials
    Groisberg, Roman
    Subbiah, Vivek
    Hong, David
    Janku, Filip
    Piha-Paul, Sarina
    Naing, Aung
    Benjamin, Robert
    Putal, Shreyas Kumar
    Somaiah, Neeta
    Conley, Anthony
    CANCER RESEARCH, 2017, 77
  • [4] Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials
    Groisberg, Roman
    Hong, David S.
    Behrang, Amini
    Hess, Kenneth
    Janku, Filip
    Piha-Paul, Sarina
    Naing, Aung
    Fu, Siqing
    Benjamin, Robert
    Patel, Shreyaskumar
    Somaiah, Neeta
    Conley, Anthony
    Meric-Bernstam, Funda
    Subbiah, Vivek
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [5] Characteristics and outcome of patients (pts) enrolled on phase I trials: A report from the Pediatric Oncology Branch, NCI
    Kim, A.
    Fox, E.
    Warren, K.
    Blaney, S.
    Berg, S.
    Adamson, P.
    Libucha, M.
    Byrley, E.
    Balis, F.
    Widemann, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] The role of surgery in patients with advanced gynaecological cancers participating in phase I clinical trials
    Vitfell-Pedersen, J.
    Yap, T. A.
    Moreno, V.
    Baird, R. D.
    Khan, A. Z.
    Barton, D. P. J.
    Kaye, S. B.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2012, 33 (02) : 211 - 213
  • [7] Shifting of patient characteristics enrolled on phase I clinical trials
    Kundranda, M.
    Fu, P.
    Patrick, L.
    Manda, S.
    Gibbons, J.
    Dowlati, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Temporal evolution of patient characteristics enrolled on phase I trials
    Dowlati, Afshin
    Kundranda, Madappa
    Manda, Sudhir
    Patrick, Lauren
    Fu, Pingfu
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (02) : 312 - 315
  • [9] Temporal evolution of patient characteristics enrolled on phase I trials
    Afshin Dowlati
    Madappa Kundranda
    Sudhir Manda
    Lauren Patrick
    Pingfu Fu
    Investigational New Drugs, 2011, 29 : 312 - 315
  • [10] Antitumor activity in advanced cancer patients with thymic malignancies enrolled in early clinical drug development programs (Phase I trials) at Gustave Roussy
    Kossai, M.
    Duchemann, B.
    Boutros, C.
    Caramella, C.
    Hollebecque, A.
    Angevin, E.
    Gazzah, A.
    Bahleda, R.
    Ileana, E.
    Massard, C.
    Vielh, P.
    Soria, J. C.
    Besse, B.
    LUNG CANCER, 2015, 89 (03) : 306 - 310
12345